Blue Horizon Founder and CMO Brian Mehling, M.D., Visits Living Fountain Orphanage in Lagos

NEW YORK, May 27, 2014 /PRNewswire/ -- Brian Mehling, M.D., an American orthopedic trauma surgeon, founder, and chief medical officer of Blue Horizon International (BHI) and Blue Horizon Charitable Foundation (BHCF), visited with orphaned children on a recent business trip to Abuja and Lagos in Nigeria. After touring the facility, meeting with the founder, and her staff, he also made a $1,000 donation to help the orphanage fulfill its vision to provide shelter for abandoned and orphaned children brought to them until they are adopted or able to lead an independent life.

"Lady Bethy, her family, and the dedicated team at Living Foundation Orphanage are making an extraordinary difference in the lives of so many abandoned and orphaned children," said Dr. Mehling. "The physical, emotional, and spiritual care they offer provides these children with the foundation to grow into whole and mature adults," he added.

Living Fountain Orphanage is a non-governmental, non-profit making organization which was established in 2007 out of the desire to provide shelter, clothing, emotional care and hope for a better future for the motherless, abandoned, and less privileged children in our society.

In a country where more than half the population live in appalling conditions, with very little income, and families are torn apart by urbanization, Living Fountain Orphanage was established by the family of Dr. Raymond and Lady Bethy Obieri and their five children, to rescue the tiniest victims of a society in turmoil and in fact, the poorest of the poor children of Lagos, Nigeria.

Dr. Mehling was in Nigeria conducting business with physicians and other medical personnel regarding Blue Horizon Stem Cells, the division of Blue Horizon International (BHI) that provides stem cell and regenerative therapies and conducts research to achieve health benefits.

Blue Horizon was founded by stem cell guru, Dr. Brian Mehling, who believes advanced stem cell therapies will soon be preferred over many surgical, pharmacological, and rehabilitative medical services. Dr. Mehling's charitable foundation is the fundraising arm of his corporation that provides charity care for people who otherwise would not have access to these treatments. The foundation also supports charities promoting healthcare education and awareness across the globe.

Uniquely positioned to take advantage of its clinical research, BHSC has safely and efficiently treated more than 600 patients with over 2,600 regenerative procedures documenting each procedure while tracking the progress of patients through their treatment cycle. Blue Horizon International Stem Cell Therapy Program is associated with The Stem Cell Centre, Hongqiao Brain Hospital and Wuhan University School of Basic Medical Science, Wuhan, China. A new lab and treatment center for orthopedic therapies is scheduled to open at Medissimo Hospital and Clinic in May 2014. For more information, please visit www.bluehorizonstemcells.com.

Blue Horizon International is a healthcare consulting company with a unique concept that combines treatment, research, and philanthropic efforts. BHI provides the highest quality care and services available in surgical and medical treatments globally, the most advanced technologies currently available in stem cell therapies, and also provides resources needed to assist children and adults who are medically underserved. For more information, please visit www.bluehorizoninternational.com.

Photo(s):
http://www.prlog.org/12328722

SOURCE Blue Horizon Charitable Foundation